0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Clinical Biomarker Testing Market Insights, Forecast to 2028
Published Date: February 2022
|
Report Code: QYRE-Auto-29X8376
Home | Market Reports | Health| Nursing
Global Clinical Biomarker Testing Market Insights Forecast to 2028
BUY CHAPTERS

Clinical Biomarker Testing Market Insights, Forecast to 2028

Code: QYRE-Auto-29X8376
Report
February 2022
Pages:112
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Clinical Biomarker Testing Market Outlook - 2028

The global Clinical Biomarker Testing market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.

Biomarker testing is a group of tests that looks for these molecular signs of health so that doctors can plan the best care during the clinic treatment.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Clinical Biomarker Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Clinical Biomarker Testing market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Clinical Biomarker Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Clinical Biomarker Testing market.

Clinical Biomarker Testing Market Scope and Market Size

Clinical Biomarker Testing market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Clinical Biomarker Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

  • Cancer
  • Metabolism
  • Infectious Disease
  • Cardiology
  • Neurology
  • Immunological Disease

Segment by Application

  • Drug Discovery
  • Nutrigenomics
  • Toxicology Testing
  • Personalized Medicine
  • Functional Genomics

By Company

  • Abbott Laboratories
  • AbbVie Inc.
  • Adaptive Biotechnologies
  • Agilent Technologies
  • BD
  • Becton Dickinson
  • Bio-Rad Laboratories
  • Danaher Corporation
  • Merck and Co.
  • Thermofisher Scientific

By Region

  • North America
  • United States
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
  • Nordic Countries
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia
  • Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Clinical Biomarker Testing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Cancer
1.2.3 Metabolism
1.2.4 Infectious Disease
1.2.5 Cardiology
1.2.6 Neurology
1.2.7 Immunological Disease
1.3 Market by Application
1.3.1 Global Clinical Biomarker Testing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Drug Discovery
1.3.3 Nutrigenomics
1.3.4 Toxicology Testing
1.3.5 Personalized Medicine
1.3.6 Functional Genomics
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Clinical Biomarker Testing Market Perspective (2017-2028)
2.2 Clinical Biomarker Testing Growth Trends by Region
2.2.1 Clinical Biomarker Testing Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Clinical Biomarker Testing Historic Market Size by Region (2017-2022)
2.2.3 Clinical Biomarker Testing Forecasted Market Size by Region (2023-2028)
2.3 Clinical Biomarker Testing Market Dynamics
2.3.1 Clinical Biomarker Testing Industry Trends
2.3.2 Clinical Biomarker Testing Market Drivers
2.3.3 Clinical Biomarker Testing Market Challenges
2.3.4 Clinical Biomarker Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Clinical Biomarker Testing Players by Revenue
3.1.1 Global Top Clinical Biomarker Testing Players by Revenue (2017-2022)
3.1.2 Global Clinical Biomarker Testing Revenue Market Share by Players (2017-2022)
3.2 Global Clinical Biomarker Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Clinical Biomarker Testing Revenue
3.4 Global Clinical Biomarker Testing Market Concentration Ratio
3.4.1 Global Clinical Biomarker Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Clinical Biomarker Testing Revenue in 2021
3.5 Clinical Biomarker Testing Key Players Head office and Area Served
3.6 Key Players Clinical Biomarker Testing Product Solution and Service
3.7 Date of Enter into Clinical Biomarker Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Clinical Biomarker Testing Breakdown Data by Type
4.1 Global Clinical Biomarker Testing Historic Market Size by Type (2017-2022)
4.2 Global Clinical Biomarker Testing Forecasted Market Size by Type (2023-2028)
5 Clinical Biomarker Testing Breakdown Data by Application
5.1 Global Clinical Biomarker Testing Historic Market Size by Application (2017-2022)
5.2 Global Clinical Biomarker Testing Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Clinical Biomarker Testing Market Size (2017-2028)
6.2 North America Clinical Biomarker Testing Market Size by Type
6.2.1 North America Clinical Biomarker Testing Market Size by Type (2017-2022)
6.2.2 North America Clinical Biomarker Testing Market Size by Type (2023-2028)
6.2.3 North America Clinical Biomarker Testing Market Share by Type (2017-2028)
6.3 North America Clinical Biomarker Testing Market Size by Application
6.3.1 North America Clinical Biomarker Testing Market Size by Application (2017-2022)
6.3.2 North America Clinical Biomarker Testing Market Size by Application (2023-2028)
6.3.3 North America Clinical Biomarker Testing Market Share by Application (2017-2028)
6.4 North America Clinical Biomarker Testing Market Size by Country
6.4.1 North America Clinical Biomarker Testing Market Size by Country (2017-2022)
6.4.2 North America Clinical Biomarker Testing Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Clinical Biomarker Testing Market Size (2017-2028)
7.2 Europe Clinical Biomarker Testing Market Size by Type
7.2.1 Europe Clinical Biomarker Testing Market Size by Type (2017-2022)
7.2.2 Europe Clinical Biomarker Testing Market Size by Type (2023-2028)
7.2.3 Europe Clinical Biomarker Testing Market Share by Type (2017-2028)
7.3 Europe Clinical Biomarker Testing Market Size by Application
7.3.1 Europe Clinical Biomarker Testing Market Size by Application (2017-2022)
7.3.2 Europe Clinical Biomarker Testing Market Size by Application (2023-2028)
7.3.3 Europe Clinical Biomarker Testing Market Share by Application (2017-2028)
7.4 Europe Clinical Biomarker Testing Market Size by Country
7.4.1 Europe Clinical Biomarker Testing Market Size by Country (2017-2022)
7.4.2 Europe Clinical Biomarker Testing Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Clinical Biomarker Testing Market Size (2017-2028)
8.2 Asia-Pacific Clinical Biomarker Testing Market Size by Type
8.2.1 Asia-Pacific Clinical Biomarker Testing Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Clinical Biomarker Testing Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Clinical Biomarker Testing Market Share by Type (2017-2028)
8.3 Asia-Pacific Clinical Biomarker Testing Market Size by Application
8.3.1 Asia-Pacific Clinical Biomarker Testing Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Clinical Biomarker Testing Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Clinical Biomarker Testing Market Share by Application (2017-2028)
8.4 Asia-Pacific Clinical Biomarker Testing Market Size by Region
8.4.1 Asia-Pacific Clinical Biomarker Testing Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Clinical Biomarker Testing Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Clinical Biomarker Testing Market Size (2017-2028)
9.2 Latin America Clinical Biomarker Testing Market Size by Type
9.2.1 Latin America Clinical Biomarker Testing Market Size by Type (2017-2022)
9.2.2 Latin America Clinical Biomarker Testing Market Size by Type (2023-2028)
9.2.3 Latin America Clinical Biomarker Testing Market Share by Type (2017-2028)
9.3 Latin America Clinical Biomarker Testing Market Size by Application
9.3.1 Latin America Clinical Biomarker Testing Market Size by Application (2017-2022)
9.3.2 Latin America Clinical Biomarker Testing Market Size by Application (2023-2028)
9.3.3 Latin America Clinical Biomarker Testing Market Share by Application (2017-2028)
9.4 Latin America Clinical Biomarker Testing Market Size by Country
9.4.1 Latin America Clinical Biomarker Testing Market Size by Country (2017-2022)
9.4.2 Latin America Clinical Biomarker Testing Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Clinical Biomarker Testing Market Size (2017-2028)
10.2 Middle East & Africa Clinical Biomarker Testing Market Size by Type
10.2.1 Middle East & Africa Clinical Biomarker Testing Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Clinical Biomarker Testing Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Clinical Biomarker Testing Market Share by Type (2017-2028)
10.3 Middle East & Africa Clinical Biomarker Testing Market Size by Application
10.3.1 Middle East & Africa Clinical Biomarker Testing Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Clinical Biomarker Testing Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Clinical Biomarker Testing Market Share by Application (2017-2028)
10.4 Middle East & Africa Clinical Biomarker Testing Market Size by Country
10.4.1 Middle East & Africa Clinical Biomarker Testing Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Clinical Biomarker Testing Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Clinical Biomarker Testing Introduction
11.1.4 Abbott Laboratories Revenue in Clinical Biomarker Testing Business (2017-2022)
11.1.5 Abbott Laboratories Recent Developments
11.2 AbbVie Inc.
11.2.1 AbbVie Inc. Company Details
11.2.2 AbbVie Inc. Business Overview
11.2.3 AbbVie Inc. Clinical Biomarker Testing Introduction
11.2.4 AbbVie Inc. Revenue in Clinical Biomarker Testing Business (2017-2022)
11.2.5 AbbVie Inc. Recent Developments
11.3 Adaptive Biotechnologies
11.3.1 Adaptive Biotechnologies Company Details
11.3.2 Adaptive Biotechnologies Business Overview
11.3.3 Adaptive Biotechnologies Clinical Biomarker Testing Introduction
11.3.4 Adaptive Biotechnologies Revenue in Clinical Biomarker Testing Business (2017-2022)
11.3.5 Adaptive Biotechnologies Recent Developments
11.4 Agilent Technologies
11.4.1 Agilent Technologies Company Details
11.4.2 Agilent Technologies Business Overview
11.4.3 Agilent Technologies Clinical Biomarker Testing Introduction
11.4.4 Agilent Technologies Revenue in Clinical Biomarker Testing Business (2017-2022)
11.4.5 Agilent Technologies Recent Developments
11.5 BD
11.5.1 BD Company Details
11.5.2 BD Business Overview
11.5.3 BD Clinical Biomarker Testing Introduction
11.5.4 BD Revenue in Clinical Biomarker Testing Business (2017-2022)
11.5.5 BD Recent Developments
11.6 Becton Dickinson
11.6.1 Becton Dickinson Company Details
11.6.2 Becton Dickinson Business Overview
11.6.3 Becton Dickinson Clinical Biomarker Testing Introduction
11.6.4 Becton Dickinson Revenue in Clinical Biomarker Testing Business (2017-2022)
11.6.5 Becton Dickinson Recent Developments
11.7 Bio-Rad Laboratories
11.7.1 Bio-Rad Laboratories Company Details
11.7.2 Bio-Rad Laboratories Business Overview
11.7.3 Bio-Rad Laboratories Clinical Biomarker Testing Introduction
11.7.4 Bio-Rad Laboratories Revenue in Clinical Biomarker Testing Business (2017-2022)
11.7.5 Bio-Rad Laboratories Recent Developments
11.8 Danaher Corporation
11.8.1 Danaher Corporation Company Details
11.8.2 Danaher Corporation Business Overview
11.8.3 Danaher Corporation Clinical Biomarker Testing Introduction
11.8.4 Danaher Corporation Revenue in Clinical Biomarker Testing Business (2017-2022)
11.8.5 Danaher Corporation Recent Developments
11.9 Merck and Co.
11.9.1 Merck and Co. Company Details
11.9.2 Merck and Co. Business Overview
11.9.3 Merck and Co. Clinical Biomarker Testing Introduction
11.9.4 Merck and Co. Revenue in Clinical Biomarker Testing Business (2017-2022)
11.9.5 Merck and Co. Recent Developments
11.10 Thermofisher Scientific
11.10.1 Thermofisher Scientific Company Details
11.10.2 Thermofisher Scientific Business Overview
11.10.3 Thermofisher Scientific Clinical Biomarker Testing Introduction
11.10.4 Thermofisher Scientific Revenue in Clinical Biomarker Testing Business (2017-2022)
11.10.5 Thermofisher Scientific Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
    Table 1. Global Clinical Biomarker Testing Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Cancer
    Table 3. Key Players of Metabolism
    Table 4. Key Players of Infectious Disease
    Table 5. Key Players of Cardiology
    Table 6. Key Players of Neurology
    Table 7. Key Players of Immunological Disease
    Table 8. Global Clinical Biomarker Testing Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 9. Global Clinical Biomarker Testing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 10. Global Clinical Biomarker Testing Market Size by Region (2017-2022) & (US$ Million)
    Table 11. Global Clinical Biomarker Testing Market Share by Region (2017-2022)
    Table 12. Global Clinical Biomarker Testing Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 13. Global Clinical Biomarker Testing Market Share by Region (2023-2028)
    Table 14. Clinical Biomarker Testing Market Trends
    Table 15. Clinical Biomarker Testing Market Drivers
    Table 16. Clinical Biomarker Testing Market Challenges
    Table 17. Clinical Biomarker Testing Market Restraints
    Table 18. Global Clinical Biomarker Testing Revenue by Players (2017-2022) & (US$ Million)
    Table 19. Global Clinical Biomarker Testing Revenue Share by Players (2017-2022)
    Table 20. Global Top Clinical Biomarker Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Biomarker Testing as of 2021)
    Table 21. Ranking of Global Top Clinical Biomarker Testing Companies by Revenue (US$ Million) in 2021
    Table 22. Global 5 Largest Players Market Share by Clinical Biomarker Testing Revenue (CR5 and HHI) & (2017-2022)
    Table 23. Key Players Headquarters and Area Served
    Table 24. Key Players Clinical Biomarker Testing Product Solution and Service
    Table 25. Date of Enter into Clinical Biomarker Testing Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Clinical Biomarker Testing Market Size by Type (2017-2022) & (US$ Million)
    Table 28. Global Clinical Biomarker Testing Revenue Market Share by Type (2017-2022)
    Table 29. Global Clinical Biomarker Testing Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 30. Global Clinical Biomarker Testing Revenue Market Share by Type (2023-2028)
    Table 31. Global Clinical Biomarker Testing Market Size by Application (2017-2022) & (US$ Million)
    Table 32. Global Clinical Biomarker Testing Revenue Share by Application (2017-2022)
    Table 33. Global Clinical Biomarker Testing Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 34. Global Clinical Biomarker Testing Revenue Share by Application (2023-2028)
    Table 35. North America Clinical Biomarker Testing Market Size by Type (2017-2022) & (US$ Million)
    Table 36. North America Clinical Biomarker Testing Market Size by Type (2023-2028) & (US$ Million)
    Table 37. North America Clinical Biomarker Testing Market Size by Application (2017-2022) & (US$ Million)
    Table 38. North America Clinical Biomarker Testing Market Size by Application (2023-2028) & (US$ Million)
    Table 39. North America Clinical Biomarker Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 40. North America Clinical Biomarker Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Europe Clinical Biomarker Testing Market Size by Type (2017-2022) & (US$ Million)
    Table 42. Europe Clinical Biomarker Testing Market Size by Type (2023-2028) & (US$ Million)
    Table 43. Europe Clinical Biomarker Testing Market Size by Application (2017-2022) & (US$ Million)
    Table 44. Europe Clinical Biomarker Testing Market Size by Application (2023-2028) & (US$ Million)
    Table 45. Europe Clinical Biomarker Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 46. Europe Clinical Biomarker Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Clinical Biomarker Testing Market Size by Type (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Clinical Biomarker Testing Market Size by Type (2023-2028) & (US$ Million)
    Table 49. Asia Pacific Clinical Biomarker Testing Market Size by Application (2017-2022) & (US$ Million)
    Table 50. Asia Pacific Clinical Biomarker Testing Market Size by Application (2023-2028) & (US$ Million)
    Table 51. Asia Pacific Clinical Biomarker Testing Market Size by Region (2017-2022) & (US$ Million)
    Table 52. Asia Pacific Clinical Biomarker Testing Market Size by Region (2023-2028) & (US$ Million)
    Table 53. Latin America Clinical Biomarker Testing Market Size by Type (2017-2022) & (US$ Million)
    Table 54. Latin America Clinical Biomarker Testing Market Size by Type (2023-2028) & (US$ Million)
    Table 55. Latin America Clinical Biomarker Testing Market Size by Application (2017-2022) & (US$ Million)
    Table 56. Latin America Clinical Biomarker Testing Market Size by Application (2023-2028) & (US$ Million)
    Table 57. Latin America Clinical Biomarker Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 58. Latin America Clinical Biomarker Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Clinical Biomarker Testing Market Size by Type (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Clinical Biomarker Testing Market Size by Type (2023-2028) & (US$ Million)
    Table 61. Middle East and Africa Clinical Biomarker Testing Market Size by Application (2017-2022) & (US$ Million)
    Table 62. Middle East and Africa Clinical Biomarker Testing Market Size by Application (2023-2028) & (US$ Million)
    Table 63. Middle East and Africa Clinical Biomarker Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 64. Middle East and Africa Clinical Biomarker Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 65. Abbott Laboratories Company Details
    Table 66. Abbott Laboratories Business Overview
    Table 67. Abbott Laboratories Clinical Biomarker Testing Product
    Table 68. Abbott Laboratories Revenue in Clinical Biomarker Testing Business (2017-2022) & (US$ Million)
    Table 69. Abbott Laboratories Recent Developments
    Table 70. AbbVie Inc. Company Details
    Table 71. AbbVie Inc. Business Overview
    Table 72. AbbVie Inc. Clinical Biomarker Testing Product
    Table 73. AbbVie Inc. Revenue in Clinical Biomarker Testing Business (2017-2022) & (US$ Million)
    Table 74. AbbVie Inc. Recent Developments
    Table 75. Adaptive Biotechnologies Company Details
    Table 76. Adaptive Biotechnologies Business Overview
    Table 77. Adaptive Biotechnologies Clinical Biomarker Testing Product
    Table 78. Adaptive Biotechnologies Revenue in Clinical Biomarker Testing Business (2017-2022) & (US$ Million)
    Table 79. Adaptive Biotechnologies Recent Developments
    Table 80. Agilent Technologies Company Details
    Table 81. Agilent Technologies Business Overview
    Table 82. Agilent Technologies Clinical Biomarker Testing Product
    Table 83. Agilent Technologies Revenue in Clinical Biomarker Testing Business (2017-2022) & (US$ Million)
    Table 84. Agilent Technologies Recent Developments
    Table 85. BD Company Details
    Table 86. BD Business Overview
    Table 87. BD Clinical Biomarker Testing Product
    Table 88. BD Revenue in Clinical Biomarker Testing Business (2017-2022) & (US$ Million)
    Table 89. BD Recent Developments
    Table 90. Becton Dickinson Company Details
    Table 91. Becton Dickinson Business Overview
    Table 92. Becton Dickinson Clinical Biomarker Testing Product
    Table 93. Becton Dickinson Revenue in Clinical Biomarker Testing Business (2017-2022) & (US$ Million)
    Table 94. Becton Dickinson Recent Developments
    Table 95. Bio-Rad Laboratories Company Details
    Table 96. Bio-Rad Laboratories Business Overview
    Table 97. Bio-Rad Laboratories Clinical Biomarker Testing Product
    Table 98. Bio-Rad Laboratories Revenue in Clinical Biomarker Testing Business (2017-2022) & (US$ Million)
    Table 99. Bio-Rad Laboratories Recent Developments
    Table 100. Danaher Corporation Company Details
    Table 101. Danaher Corporation Business Overview
    Table 102. Danaher Corporation Clinical Biomarker Testing Product
    Table 103. Danaher Corporation Revenue in Clinical Biomarker Testing Business (2017-2022) & (US$ Million)
    Table 104. Danaher Corporation Recent Developments
    Table 105. Merck and Co. Company Details
    Table 106. Merck and Co. Business Overview
    Table 107. Merck and Co. Clinical Biomarker Testing Product
    Table 108. Merck and Co. Revenue in Clinical Biomarker Testing Business (2017-2022) & (US$ Million)
    Table 109. Merck and Co. Recent Developments
    Table 110. Thermofisher Scientific Company Details
    Table 111. Thermofisher Scientific Business Overview
    Table 112. Thermofisher Scientific Clinical Biomarker Testing Product
    Table 113. Thermofisher Scientific Revenue in Clinical Biomarker Testing Business (2017-2022) & (US$ Million)
    Table 114. Thermofisher Scientific Recent Developments
    Table 115. Research Programs/Design for This Report
    Table 116. Key Data Information from Secondary Sources
    Table 117. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Clinical Biomarker Testing Market Share by Type: 2021 VS 2028
    Figure 2. Cancer Features
    Figure 3. Metabolism Features
    Figure 4. Infectious Disease Features
    Figure 5. Cardiology Features
    Figure 6. Neurology Features
    Figure 7. Immunological Disease Features
    Figure 8. Global Clinical Biomarker Testing Market Share by Application: 2021 VS 2028
    Figure 9. Drug Discovery Case Studies
    Figure 10. Nutrigenomics Case Studies
    Figure 11. Toxicology Testing Case Studies
    Figure 12. Personalized Medicine Case Studies
    Figure 13. Functional Genomics Case Studies
    Figure 14. Clinical Biomarker Testing Report Years Considered
    Figure 15. Global Clinical Biomarker Testing Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 16. Global Clinical Biomarker Testing Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 17. Global Clinical Biomarker Testing Market Share by Region: 2021 VS 2028
    Figure 18. Global Clinical Biomarker Testing Market Share by Players in 2021
    Figure 19. Global Top Clinical Biomarker Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Biomarker Testing as of 2021)
    Figure 20. The Top 10 and 5 Players Market Share by Clinical Biomarker Testing Revenue in 2021
    Figure 21. North America Clinical Biomarker Testing Market Size YoY (2017-2028) & (US$ Million)
    Figure 22. North America Clinical Biomarker Testing Market Size Market Share by Type (2017-2028)
    Figure 23. North America Clinical Biomarker Testing Market Size Market Share by Application (2017-2028)
    Figure 24. North America Clinical Biomarker Testing Market Size Share by Country (2017-2028)
    Figure 25. United States Clinical Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Canada Clinical Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Europe Clinical Biomarker Testing Market Size YoY (2017-2028) & (US$ Million)
    Figure 28. Europe Clinical Biomarker Testing Market Size Market Share by Type (2017-2028)
    Figure 29. Europe Clinical Biomarker Testing Market Size Market Share by Application (2017-2028)
    Figure 30. Europe Clinical Biomarker Testing Market Size Share by Country (2017-2028)
    Figure 31. Germany Clinical Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. France Clinical Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. U.K. Clinical Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Italy Clinical Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Russia Clinical Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Nordic Countries Clinical Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Asia-Pacific Clinical Biomarker Testing Market Size YoY (2017-2028) & (US$ Million)
    Figure 38. Asia Pacific Clinical Biomarker Testing Market Size Market Share by Type (2017-2028)
    Figure 39. Asia Pacific Clinical Biomarker Testing Market Size Market Share by Application (2017-2028)
    Figure 40. Asia Pacific Clinical Biomarker Testing Market Size Share by Region (2017-2028)
    Figure 41. China Clinical Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Japan Clinical Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. South Korea Clinical Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Southeast Asia Clinical Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. India Clinical Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Australia Clinical Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 47. Latin America Clinical Biomarker Testing Market Size YoY (2017-2028) & (US$ Million)
    Figure 48. Latin America Clinical Biomarker Testing Market Size Market Share by Type (2017-2028)
    Figure 49. Latin America Clinical Biomarker Testing Market Size Market Share by Application (2017-2028)
    Figure 50. Latin America Clinical Biomarker Testing Market Size Share by Country (2017-2028)
    Figure 51. Mexico Clinical Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 52. Brazil Clinical Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. Middle East & Africa Clinical Biomarker Testing Market Size YoY (2017-2028) & (US$ Million)
    Figure 54. Middle East and Africa Clinical Biomarker Testing Market Size Market Share by Type (2017-2028)
    Figure 55. Middle East and Africa Clinical Biomarker Testing Market Size Market Share by Application (2017-2028)
    Figure 56. Middle East and Africa Clinical Biomarker Testing Market Size Share by Country (2017-2028)
    Figure 57. Turkey Clinical Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 58. Saudi Arabia Clinical Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 59. UAE Clinical Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 60. Abbott Laboratories Revenue Growth Rate in Clinical Biomarker Testing Business (2017-2022)
    Figure 61. AbbVie Inc. Revenue Growth Rate in Clinical Biomarker Testing Business (2017-2022)
    Figure 62. Adaptive Biotechnologies Revenue Growth Rate in Clinical Biomarker Testing Business (2017-2022)
    Figure 63. Agilent Technologies Revenue Growth Rate in Clinical Biomarker Testing Business (2017-2022)
    Figure 64. BD Revenue Growth Rate in Clinical Biomarker Testing Business (2017-2022)
    Figure 65. Becton Dickinson Revenue Growth Rate in Clinical Biomarker Testing Business (2017-2022)
    Figure 66. Bio-Rad Laboratories Revenue Growth Rate in Clinical Biomarker Testing Business (2017-2022)
    Figure 67. Danaher Corporation Revenue Growth Rate in Clinical Biomarker Testing Business (2017-2022)
    Figure 68. Merck and Co. Revenue Growth Rate in Clinical Biomarker Testing Business (2017-2022)
    Figure 69. Thermofisher Scientific Revenue Growth Rate in Clinical Biomarker Testing Business (2017-2022)
    Figure 70. Bottom-up and Top-down Approaches for This Report
    Figure 71. Data Triangulation
    Figure 72. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS